|
ARE
|
Alexandria Real Estate Equities, Inc.
|
2.07%
|
US
|
NYSE
|
|
GMAB
|
Genmab A/S
|
2.05%
|
US
|
NASDAQ
|
|
NOVT
|
Novanta Inc.
|
1.71%
|
US
|
NASDAQ
|
|
DHR
|
Danaher Corporation
|
1.59%
|
US
|
NYSE
|
|
WST
|
West Pharmaceutical Services, Inc.
|
1.38%
|
US
|
NYSE
|
|
IDXX
|
IDEXX Laboratories, Inc.
|
1.36%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
1.23%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
1.06%
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
1.01%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
1.01%
|
US
|
NASDAQ
|
|
SWAV
|
ShockWave Medical, Inc.
|
1.00%
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
0.96%
|
US
|
NYSE
|
|
ALGN
|
Align Technology, Inc.
|
0.87%
|
US
|
NASDAQ
|
|
AXNX
|
Axonics Modulation Technologies, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
LONN
|
Lonza Group AG
|
0.76%
|
CH
|
SW
|
|
EXEL
|
Exelixis, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
ZTS
|
Zoetis Inc.
|
0.65%
|
US
|
NYSE
|
|
NARI
|
Inari Medical, Inc.
|
0.60%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
0.56%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
0.55%
|
US
|
NASDAQ
|